Characterization of VRDN-001, a High Affinity and Potent Anti-IGF-1R Inhibitory Antibody in Development for the Treatment of Thyroid Eye Disease

Update Item Information
Identifier 20220213_nanos_posters_332
Title Characterization of VRDN-001, a High Affinity and Potent Anti-IGF-1R Inhibitory Antibody in Development for the Treatment of Thyroid Eye Disease
Creator Hyunjin Shin, Jung-Won You, Ki-Seok Koh, Wu-Chul Song
Subject Graves' Disease; Orbit/Ocular Pathology; Neuro-ophth & Systemic Disease (eg. MS, MG, Thyroid); Orbit
Description VRDN-001 is an antagonist antibody to insulin-like growth factor-1 receptor (IGF-1R) under development by Viridian Therapeutics for Thyroid Eye Disease (TED). TED is characterized by recruitment of fibrocytes that express IGF-1R and TSHR into orbital tissues, where they mediate deposition of hyaluronan and expansion of orbital tissues. We evaluated the binding characteristics of VRDN-001 to IGF-1R and its potency for inhibition of IGF-1R phosphorylation.
Date 2022-02
Language eng
Format application/pdf
Type Text
Source 2022 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2022: Poster Session I: Orbital and Eyelid Disorders
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2022. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6zr5t7t
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Hyunjin Shin
Contributor Secondary Jung-Won You, Ki-Seok Koh, Wu-Chul Song
Setname ehsl_novel_nam
ID 2065352
Reference URL https://collections.lib.utah.edu/ark:/87278/s6zr5t7t
Back to Search Results